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Abstract 8 
Hormonal synchronization protocols can dramatically improve the reproductive 9 
efficiency of dairy herds, yet some farmers continue to question the economics of these 10 
programs based on the cost of hormonal treatments, and hormonal treatment costs vary 11 
dramatically among countries. Our objective was to compare the economic impact of 12 
reproductive management programs that incorporate varying degrees of detection of estrus and 13 
timed AI. A reproductive economic analysis simulation model (the UW-Cornell 14 
DairyRepro$ decision tool) was used to compare the economic impact of pairs of reproductive 15 
management programs. We simulated sets of scenarios for 2 analyses. In the first analysis, we 16 
calculated the economic impact of switching from a Presynch-Ovsynch program to a Double-17 
Ovsynch program that included a second PGF2α treatment during the Breeding-Ovsynch 18 
portion of the protocol (Double-Ovsynch+PGF). In the second analysis, we conducted a 19 
breakeven analysis in which we incrementally increased the cost of hormonal treatments within 20 
various reproductive management programs. Our analyses revealed that a Double-21 
Ovsynch+PGF protocol, the most intensive program evaluated, was more profitable than other 22 
programs including a Presynch-Ovsynch protocol with 100% timed AI or a Presynch-Ovsynch 23 
  2 
protocol that incorporated detection of estrus, despite the higher up-front cost incurred by using 24 
more hormonal treatments. This advantage remained until the cost of hormones were 5 to 14 25 
times more than the current US market prices and 2 to 6 times greater than the current 26 
European market prices. The cost of GnRH had a greater impact on the net profit gain than the 27 
cost of PGF2α.  28 
Keywords: reproduction, intensive synchronization program, economic impact 29 
 Short Communication 30 
Advances in the understanding of the reproductive physiology of dairy cows have lead 31 
to the development of management strategies and technologies that improve reproductive 32 
performance. Commercial dairy farms are challenged with making the most profitable 33 
management decisions among many options and implementing them correctly. Methods for 34 
enhancing fertility and breeding efficiency include: detection of estrus (ED) (Xu et al., 1998; 35 
Rorie et al., 2002), synchronization of estrus (Folman et al., 1984; Momcilovic et al., 1998), 36 
and synchronization of ovulation and timed artificial insemination (TAI) (Pursley et al., 1995; 37 
Moreira et al., 2001; Souza et al., 2008). The newest TAI protocols for first AI (i.e., Double-38 
Ovsynch and G6G), not only increase the AI service rate, but also increase P/AI to TAI 39 
(Carvalho et al., 2018). Strategies that maximize ED, which is widely implemented on dairies, 40 
have made significant contributions to the profitability of dairy herds (Pecsok et al. 1994). A 41 
major limitation of ED, however, is the presence of anovular cows. The proportion of cows that 42 
have not re-initiated cyclicity by the end of the voluntary waiting period varies among herds 43 
and among parities within a herd and ranges from 5% to 40% (Walsh et al., 2007; Santos et al., 44 
2009; Bamber et al., 2009). The lack of estrous behavior in anovular cows precludes AI to a 45 
detected estrus, and many anovular cows are submitted to hormonal protocols for TAI.  46 
  3 
Protocols for synchronization of ovulation use sequential treatments of GnRH and 47 
PGF2α to control follicular development, luteal regression, and time of ovulation. 48 
Synchronization of ovulation allows for more precise timing of AI than relying on detection of 49 
estrus alone for the timing of AI (Pursley et al., 1995, Souza et al. 2008; Valenza et al., 2012; 50 
Fricke et al., 2014). Furthermore, optimization of the hormonal milieu during the Ovsynch 51 
protocol increases P/AI for cows at first TAI (Souza et al., 2008; Carvalho et al., 2014) and for 52 
cows resynchronized to receive subsequent TAI (Giordano et al., 2012; Lopes et al., 2013; 53 
Carvalho et al., 2015). Many farms combine ED and TAI by observing and inseminating cows 54 
detected in estrus after the second PGF2α treatment of a Presynch-Ovsynch protocol 55 
(Stangaferro et al. 2018 and 2019), whereas cows not detected in estrus complete the protocol 56 
and receive TAI. Although incorporation of estrus into a Presynch-Ovsynch protocol increases 57 
AI service rate, it also decreases P/AI by 35% compared to 100% TAI after a Presynch-58 
Ovsynch protocol (Borchardt et al., 2016). By contrast, submission of lactating Holstein cows 59 
to a Double-Ovsynch+PGF protocol and TAI for first insemination increases the percentage of 60 
cows inseminated within 7 d after the end of the voluntary waiting period and increases P/AI at 61 
33 and 63 d after first insemination resulting in 64 and 58% more pregnant cows, respectively, 62 
than submission of cows for first AI after detection of estrus at a similar day in milk range 63 
(Santos et al., 2017).  64 
The assessment of the overall economic value of different reproductive management 65 
programs (Cabrera and Giordano, 2013; Cabrera, 2014) can be achieved by simulating 66 
reproductive performance along with its costs and benefits on a farm-by-farm basis (Giordano 67 
et al., 2011; 2012; Kalantari and Cabrera, 2012), and calculating the expected net return (De 68 
Vries et al., 2010; Fricke et al., 2010; Cabrera, 2011). In this study, we used a simulation model 69 
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to compare the economic impact of current and alternative reproductive programs (the UW-70 
Cornell DairyRepro$ decision tool; Giordano et al., 2012). This study had three major 71 
objectives: 1) to analyze the economic profitability of a more intensive reproductive protocol 72 
involving more hormonal treatments; 2) to determine if increased hormonal treatment costs 73 
would be compensated for by increased production of calves and increased P/AI; and 3) to 74 
estimate how high the cost of hormones would have to be to render intensive synchronization 75 
protocols that require more hormonal treatments non-profitable. To answer to these questions, 76 
a 1,000-cow commercial dairy herd was simulated using the UW-Cornell 77 
DairyRepro$ decision tool. For comparison consistency and to avoid analysis bias, non-studied 78 
variables such as mortality rate, body weight, involuntary culling rate, lactation curves, milk 79 
price, among others, were kept constant among scenarios at default levels described by 80 
Giordano et al. (2012). 81 
Six reproductive management programs for first TAI were simulated. The first program 82 
simulated was a PreSynch-Ovsynch protocol with ED incorporated after the second PGF2α 83 
treatment (PreSynch-Ovsynch+ED). The second program simulated was a PreSynch-Ovsynch 84 
protocol for 100% TAI with ED incorporated after first TAI (PreSynch-Ovsynch+EDpost). In 85 
these first two protocols, CR for PreSynch-Ovsynch was set at 35% (Caraviello et al., 2006), 86 
Service Rate (SR) for ED was set at 60%, and CR for ED was set at 30% (Giordano et al., 2012; 87 
Fricke et al., 2014). Programs 3 through 5 were Presynch-Ovsynch protocols for 100% TAI 88 
which were simulated with varying CR to TAI (35%, 40%, 45%; Caraviello et al., 2006; Sousa 89 
et al., 2008; Stangaferro et al., 2018). The sixth protocol simulated was a Double-90 
Ovsynch+PGF protocol (Carvalho et al., 2015; Wiltbank et al., 2015) in which CR was set at 91 
50% (Souza et al., 2008; 2013; Santos et al., 2017). In all simulations, Ovsynch was used as the 92 
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resynch protocol, with a 30% CR to TAI (Lopes et al., 2013). These protocols were chosen to 93 
reveal the difference in profitability between the most intensive program (i.e., a Double-94 
Ovsynch+PGF protocol) compared to a PreSych-Ovsynch protocol. The protocols that 95 
incorporated ED were selected to understand if incorporation of AI to a detected estrus during 96 
these programs would be profitable if performed with PreSych-Ovsynch, and this profitability 97 
difference was calculated compared to a Double-Ovsynch+PGF protocol.   98 
Because our objective was to compare the difference in hormonal costs among the 99 
programs, all non-hormonal reproduction costs were set at $0 in the UW-Cornell 100 
DairyRepro$ decision tool. The cost of each GnRH treatment was set at $2.6, and the cost of 101 
each PGF2α treatment was set to $2.3 to reflect cost of hormones in the US market (Giordano et 102 
al., 2012). In addition, the cost of each GnRH treatment was set at $6.7 and the cost of each 103 
PGF2α treatment was set to $5.1 to reflect cost of hormones in the European market. Cost of 104 
hormonal treatments for the European market were based on 11 values for the most common 105 
commercial PGF2α products (Cloprostenol 500 μg) and 5 values of the most common GnRH 106 
(Gonadorelin 100 μg) products in the Italian market in November, 2018. Based on these costs, 107 
the economic simulations were run to calculate the total net profit ($/cow per yr) and the 108 
aggregated hormonal cost of each program. The UW-Cornell DairyRepro$ decision tool was 109 
also used to calculate the number of hormonal treatments required per cow per yr for the 110 
various protocols.  111 
Using the PreSynch-Ovsynch protocol with a 35% P/AI as the baseline, the number of 112 
hormonal treatments and net profit gain of the various reproductive management protocols was 113 
compared (Table 1). Although PreSynch-Ovsynch protocols use fewer hormonal treatments 114 
than a Double-Ovsynch+PGF protocol (1.4 to 3.0 fewer treatments per cow per yr); the 115 
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Double-Ovsynch+PGF protocol was more profitable. The Double-Ovsynch+PGF protocol 116 
attained $40.4 greater profit per cow per yr than the PreSynch-Ovsynch + ED protocol and 117 
$28.9 more than PreSynch-Ovsynch + EDpost protocol based on hormonal costs in the US 118 
market. Also, the Double-Ovsynch+PGF protocol was more profitable than the 100% TAI after 119 
a Presynch-Ovsynch protocol ($21.2 to $46.2 more per cow per yr, depending on CR; Table 1). 120 
These results are directly related to the increased reproductive performance of a Double-121 
Ovsynch+PGF protocol (higher CR to first AI) compared to the other protocols. Furthermore, 122 
inclusion of ED after the first TAI (i.e., the PreSych-Ovsynch + EDpost protocol) was a more 123 
profitable strategy than using ED either before the first TAI (i.e., the PreSynch-Ovsynch + ED 124 
protocol) or not incorporating ED at all based on 35% and 40% CR, respectively. This outcome 125 
might result because fewer cows are submitted to a resynch protocol at a lower CR when 126 
applying more intensive protocols for first TAI that have an increased conception rate. The 127 
PreSynch-Ovsynch protocol with a 45% CR had the second greatest net profit among the 128 
programs compared because of its higher CR counteracting the resynch cost. The gain in 129 
profitability when switching to a Double-Ovsynch+PGF protocol based on US market prices 130 
was greater (Table 1) because of the ratio of the costs between GnRH and PGF2α, which was 131 
113% in the US market compared to131% in the European market. 132 
The second comparison we made addressed the concern of whether a more intensive 133 
synchronization protocol will still result in higher profitability than the less intensive 134 
reproductive management protocols based on higher costs of hormones. We therefore 135 
conducted sensitivity analyses by incrementally increasing the cost of hormonal treatments to 136 
determine the breakeven point at which hormonal costs offset the net profit of 1) having the 137 
costs of GnRH and PGF2α at US and European market costs and raising both costs by multiples; 138 
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2) setting the cost of GnRH at European market average cost of $6.7 and increasing the cost of 139 
PGF2α; and 3) setting the cost of PGF2α  at European market average cost of $5.1 and increasing 140 
the cost of GnRH. The ability to vary hormonal treatment costs in the UW-Cornell 141 
DairyRepro$ decision tool made it possible to simulate these scenarios. For this analysis, all 142 
general costs such as labor for administering hormonal treatments, labor for transrectal 143 
palpation for pregnancy diagnosis and insemination, and the non-studied variables like 144 
lactation curve and other herd parameters, were kept as default in the UW-Cornell 145 
DairyRepro$ decision tool (Giordano et al., 2012). Briefly, labor cost for administering 146 
hormonal treatments was set at $15/hr, and labor for transrectal palpation for pregnancy 147 
diagnosis was set at $105/hr. The cost of insemination included semen cost of $5/AI and a 148 
labor cost of insemination at $5/AI. Groups of simulations were run to compare the most 149 
intensive Double-Ovsynch+PGF protocol with each of the other defined protocols compared in 150 
this simulation. In each pair-group comparison, the cost of GnRH and/or PGF2α treatments was 151 
increased until the net profit became negative, then the breakeven point was identified as the 152 
intercept of the trend line with the x-axis (Figure 1). These x-axis intercepts define the 153 
hormonal treatment costs at which a Double-Ovsynch+PGF protocol would have an equal net 154 
profit to the protocol it was compared against.  155 
Based on our analysis hormonal treatment costs would need to be 5 to 14 times greater 156 
in the US market and 2 to 6 times greater in the European market for any of the Presynch-157 
Ovsynch protocols to be more profitable than the Double-Ovsynch+PGF protocol. The greater 158 
P/AI at first insemination after a Double-Ovsynch+PGF protocol compensates for the 159 
additional hormonal treatment costs so that the cost of hormonal treatments would need to 160 
increase substantially before it becomes less profitable than any of the other programs. When 161 
  8 
the CR of Presynch-Ovsynch protocols increased, the breakeven point was reached earlier 162 
because the advantage of the increased CR of Double-Ovsynch+PGFis was decreased. 163 
To investigate the cost of one of the hormonal treatments to reach the breakeven point, 164 
we ran hypothetical scenarios in which the cost of one hormone was constant but the cost for 165 
the other hormone was incrementally increased. In this simulation, the cost of PGF2α was set at 166 
$5.1/dose, and the cost of GnRH was set at $6.7/dose (i.e., the average European market price). 167 
Breakeven hormonal costs from this analysis are reported in Table 2.  168 
Overall, the breakeven cost was more sensitive to the cost of GnRH than to the cost of 169 
the PGF2α (Table 2). When the cost of GnRH was fixed, the cost of PGF2α could increase 170 
considerably before the breakeven point was reached or no breakeven point could be reached 171 
by the model. A complete Presynch-Ovsynch protocol uses 2 GnRH and 3 PGF2α treatments, 172 
whereas the Double-Ovsynch+PGF protocol uses 4 GnRH and 3 PGF2α treatments with a 173 
higher proportion of GnRH treatments (57% vs. 40%) and a lower proportion of PGF2α 174 
treatments (43% vs. 60%). If ED was not incorporated into the reproductive program and the 175 
cost of GnRH was fixed, profit increased even when the cost of PGF2α increased. Thus, the 176 
breakeven points are not reached by the model when increasing the cost of PGF2α. For example, 177 
when compared with PreSyncOv 40 with the cost of PGF2α fixed at $5.1/dose, the cost of a 178 
GnRH treatment was $22.4/dose at the break-even point (Table 2). By contrast, in the first 179 
study, one breakeven point was reached when the price was $20.7/dose for PGF2α and 180 
$23.4/dose for GnRH (Figure 1(a), 9 times the US market prices), indicating that a greater 181 
PGF2α cost determines an even higher cost of GnRH to reach the breakeven point. This can be 182 
explained by the higher CR of the Double-Ovsynch+PGF protocol that leads to fewer cows 183 
submitted to a resynch protocol. Consequently, fewer GnRH treatments per pregnancy are used 184 
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on average (Table 1). For protocols that incorporate ED, fewer cows are submitted to hormonal 185 
treatments which decreases total hormone costs of the protocol; thus, a breakeven point was 186 
reached even when the GnRH cost was fixed, but when the cost of PGF2α was unusually high 187 
(Table 2).  188 
In conclusion, our economic evaluation found that more intensive reproductive 189 
programs that use more hormonal treatments but result in substantially increased reproductive 190 
performance are more profitable than less intensive programs and remain superior even if 191 
hormonal prices are unusually high. Results from these analyses could be reproduced or 192 
adjusted by applying the UW-Cornell DairyRepro$ decision support tool that is openly 193 
available at UW-Madison and Cornell University websites. 194 
  195 
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Table 1. Comparison in the number of hormonal treatments and net profit between different 300 
reproductive synchronization programs. 301 
1Approximated number of treatments for hormones. GnRH proportion in protocols: Presynch-302 
Ovsynch protocols: 40%; Double-Ovsynch+PGFprotocol: 57%. 303 
2Net profit gain over the baseline is the value of the net profit difference when alternating the 304 
baseline protocol to the listed one. 305 
3PreSynch-Ovsynch (Presynch-Ovsynch protocol with 35%, 40%, 45% CR), ED (Estrus 306 
detection performed before first AI service with 60% SR and 30% CR), EDpost (Estrus 307 
detection performed after first AI protocol with 60% SR and 30% CR), Double-Ovsynch 308 
PG2x (Double Ovsynch with a repeated injection at second prostaglandin with 50% CR).  309 
4PGF2α at $2.3/dose and GnRH at $2.6/dose
 representing the US market and PGF2α at $5.1/dose 310 
and GnRH at $6.7/dose representing the European market.  311 
 312 
Reproductive Program3 P/AI (%) 
Approximated number of 
treatments1 
(#/cow per yr) 
Net Profit gain over the 
baseline2 
($/cow per yr) 
Total GnRH PGF2α  
PGF2α at $2.3 
and GnRH at 
$2.64 
PGF2α at $5.1 




35 7.8 3.12 4.68 - - 
PreSynch-Ovsynch 40 7.6 3.04 4.56 12.7 13.7 
PreSynch-Ovsynch 45 7.4 2.96 4.44 25 26.7 
PreSynch-Ovsynch + 
ED 
35 + 30 6.2 2.48 3.72 5.8 8.2 
PreSynch-Ovsynch + 
EDpost 
35 + 30 6.3 2.52 3.78 17.3 22.8 
Double-Ovsynch+PGF 50 9.2 5.24 3.96 46.2 32.1 
  16 
  313 
  17 
Table 2. The cost ($/dose) of GnRH or PGF2α at breakeven profit points (bold numbers), when 314 
the other hormonal cost was set constant at European market price, comparing Presynch-315 
Ovsynch programs against the most intensive synchronization program, the Double-316 
Ovsynch+PGF. 317 
 Cost ($/dose) at the breakeven point compared with Double-Ovsynch+PGF1 
Hormones Presynch-Ovsynch2 
Presynch-Ovsynch (35% CR) 
+ ED 
 35% CR 40% CR 45% CR ED3  EDpost4  
GnRH 32.8 6.7 22.4 6.7 14.2 6.7 19.0 6.7 13.7 6.7 
PGF2α  5.1 --
5 5.1 --5 5.1 --5 5.1 97.0 5.1 63.0 
1Double-Ovsynch PG2x (Double-Ovsynch+PGF with 50% CR). 318 
2PreSynch-Ovsynch (Presynch-Ovsynch protocol with 35%, 40%, 45% CR). 319 
3ED (Estrus detection performed before first AI service with 60% SR and 30% CR).  320 
4EDpost (Estrus detection performed after first AI protocol with 60% SR and 30% CR). 321 
5The breakeven point could not be reached. 322 
 323 
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Figure 1. Sensitive analysis by identifying the breakeven points when the net profit gain by 325 
switching the Presynch-Ovsynch protocols to Double-Ovsynch+PGF protocol become negative 326 
with multiples of GnRH and PGF2α for US market price (a) and European market price (b). 327 
PreSynchOv 35 (Presync-Ovsynch protocol with 35% CR)  328 
PreSynchOv 40 (Presync-Ovsynch protocol with 40% CR)  329 
PreSynchOv 45 (Presync-Ovsynch protocol with 45% CR)  330 
PreSynchOv + ED (Presync-Ovsynch protocol with 35% CR + estrus detection before first AI 331 
service with 60% SR and 30% CR) 332 
PreSynchOv + EDpost (Presync-Ovsynch protocol with 35% CR + estrus detection after first AI 333 
service with 60% SR and 30% CR) 334 
Double-Ovsynch PG2x (Double Ovsynch with a repeated injection at second prostaglandin with 335 
50% CR) 336 
 337 
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